The Xolair dose and dosing interval were determined by total serum immunoglobulin E (IgE) level and body weight at baseline. After 16 to 20 weeks of treatment with Xolair or placebo, each participant ...
CHICAGO (WLS) -- After the FDA approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods, sufferers say they're ...
If you have food allergies, you know the dread: You'll be at a gathering and no one can tell you for sure if there are peanuts or eggs in any of the food. So you take a risk or you don't eat. Now, a ...
Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...
Findings showed that compared with placebo, Xolair significantly increased the amount of peanut, milk, egg, and cashew participants could consume without an allergic reaction. The Food and Drug ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair ...
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results